Pas de connexion internet — affichage de la version enregistrée de la page.

Opko Health Inc

USUSD
← Vers le screener
US:OPKLSE:0KCS

Opko Health Inc (US:OPK) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
opko.com
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège social
Miami, United States
PDG
Phillip Frost
Employés
2 275
Fondée
1991
Actions en circulation
746.33 M au 2026-07-17
Flottant
323.73 M
Capitalisation boursière
1.17 Md USD
Initiés
50.52%
Investisseurs institutionnels
27.56%
Secteur d'activité (SIC)
Pharmaceutical Preparations
ISIN
US68375N1037
LEI
529900A4S2D4OGOJLL02
FCF
−134 M USD
Dette
349 M USD
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksOPK principaleUSD1.37 -1.44%actions ordinaires
LSE London Stock Exchange0KCS IOBUSD1.64 +0.00%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Actualités de cette semaine

Aucune actualité au cours de la dernière semaine. Dernière actualité : 08.09.2026.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
Rubric Capital Managemen…6.4%47.79 M2026-06-30
Blackrock Inc.4.95%36.98 M2026-06-30
Vanguard Capital Managem…2.01%14.97 M2026-06-30
Vanguard Portfolio Manag…2%14.93 M2026-06-30
Geode Capital Management…1.55%11.58 M2026-06-30
iShares Trust-iShares Ru…1.38%10.32 M2026-08-31
State Street Corporation1.38%10.31 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.31%9.75 M2026-06-30
Goldman Sachs Group Inc0.94%7.04 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%6.92 M2026-06-30
UBS Group AG0.67%5.01 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.66%4.91 M2026-06-30
Whitefort Capital Manage…0.6%4.51 M2026-06-30
Fidelity Salem Street Tr…0.58%4.35 M2026-07-31
iShares Trust-iShares Ru…0.51%3.79 M2026-08-31
Northern Trust Corporati…0.5%3.76 M2026-06-30
iShares Trust-iShares Bi…0.38%2.81 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.29%2.2 M2026-06-30
VANGUARD SCOTTSDALE FUND…0.28%2.11 M2026-05-31
SCHWAB STRATEGIC TRUST-S…0.27%2.04 M2026-05-31
PAGANELLI JOHN A (Direct…≈0.05%403 5152026-03-20
FROST PHILLIP MD ET AL (…——2025-11-21